Disease characteristics, effectiveness, and safety of vestronidase alfa for the treatment of patients with mucopolysaccharidosis VII in a novel, longitudinal, multicenter disease monitoring program.
第一作者:
Roberto,Giugliani
第一单位:
Dep Genetics UFRGS, Casa dos Raros, INAGEMP, Med Genet Serv HCPA, and DASA Genomics, Porto Alegre, Brazil. rgiugliani@hcpa.edu.br.
作者:
医学主题词
人类(Humans);黏多糖累积病Ⅶ型(Mucopolysaccharidosis VII);葡糖醛酸糖苷酶(Glucuronidase);男(雄)性(Male);儿童, 学龄前(Child, Preschool);女(雌)性(Female);儿童(Child);酶替代疗法(Enzyme Replacement Therapy);重组蛋白质类(Recombinant Proteins);婴儿(Infant);纵向研究(Longitudinal Studies);青少年(Adolescent)
DOI
10.1186/s13023-024-03176-z
PMID
38715031
发布时间
2026-05-14
- 浏览3
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



